We are live on ! Find out more
PBAXU

Phoenix Biotech Acquisition Corp. Unit
PBAXU

Delisted

PBAXU was delisted on the 7th of February, 2024.

Back to rankings

26 hedge funds and large institutions have $25.9M invested in Phoenix Biotech Acquisition Corp. Unit in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 28 → 26 (-2)

21% less capital invested

Capital invested by funds: $32.6M → $25.9M (-$6.71M)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CSS
Cubist Systematic Strategies
Connecticut
+$235K
2
WAM
Wolverine Asset Management
Illinois
+$126K
3
UBS Group
UBS Group
Switzerland
+$1.16K

Top Sellers

1
MP
Mangrove Partners
Connecticut
-$2.01M
2
SRCM
Sage Rock Capital Management
New York
-$1.85M
3
MF
Magnetar Financial
Illinois
-$679K
4
WC
Wealthspring Capital
New York
-$494K
5
SMA
Sage Mountain Advisors
Georgia
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$2K – – –
MP
27
Mangrove Partners
Connecticut
– -$2.01M -199,900 Closed
SRCM
28
Sage Rock Capital Management
New York
– -$1.85M -184,000 Closed
CS
29
Clear Street
New York
– -$9K -853 Closed
1
2